The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Toxin Models of Mitochondrial Dysfunction in Parkinson's Disease
Open accessAbstract
SIGNIFICANCE: Parkinson's disease (PD) is a neurodegenerative disorder characterized, in part, by the progressive and selective loss of dopaminergic neuron cell bodies within the substantia nigra pars compacta (SNpc) and the associated deficiency of the neurotransmitter dopamine (DA) in the striatum, which gives rise to the typical motor symptoms of PD. The mechanisms that contribute to the induction and progressive cell death of dopaminergic neurons in PD are multi-faceted and remain incompletely understood. Data from epidemiological studies in humans and molecular studies in genetic, as well as toxin-induced animal models of parkinsonism, indicate that mitochondrial dysfunction occurs early in the pathogenesis of both familial and idiopathic PD. In this review, we provide an overview of toxin models of mitochondrial dysfunction in experimental Parkinson's disease and discuss mitochondrial mechanisms of neurotoxicity. RECENT ADVANCES: A new toxin model using the mitochondrial toxin trichloroethylene was recently described and novel methods, such as intranasal exposure to toxins, have been explored. Additionally, recent research conducted in toxin models of parkinsonism provides an emerging emphasis on extranigral aspects of PD pathology. CRITICAL ISSUES: Unfortunately, none of the existing animal models of experimental PD completely mimics the etiology, progression, and pathology of human PD. FUTURE DIRECTIONS: Continued efforts to optimize established animal models of parkinsonism, as well as the development and characterization of new animal models are essential, as there still remains a disconnect in terms of translating mechanistic observations in animal models of experimental PD into bona fide disease-modifying therapeutics for human PD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Thiruchelvam, M., Prokopenko, O., Cory-Slechta, D., Richfield, E., Buckley, B., & Mirochnitchenko, O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500417200 · Cited by 84
RetractedMutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Self-citationStages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
Dorsey, E. R., Constantinescu, R., Thompson, J. P., Biglan, K. M., Holloway, R. G., Kieburtz, K., Marshall, F. J., Ravina, B. M., Schifitto, G., Siderowf, A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000247740.47667.03 · Cited by 2,472
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
Burns, R. S., Chiueh, C. C., Markey, S. P., Ebert, M. H., Jacobowitz, D. M., & Kopin, I. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.14.4546 · Cited by 2,149
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
THE MITOCHONDRIAL ELECTRON TRANSPORT AND OXIDATIVE PHOSPHORYLATION SYSTEM
Hatefi, Y. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.005055 · Cited by 1,680
Rotenone, Paraquat, and Parkinson’s Disease
Tanner, C. M., Kamel, F., Ross, G. W., Hoppin, J. A., Goldman, S. M., Korell, M., Marras, C., Bhudhikanok, G. S., Kasten, M., Chade, A. R., et al. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002839 · Cited by 1,475
Nicklas, W. J., Vyas, I., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,262
Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
Chiba, K., Trevor, A., & Castagnoli, N. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91293-2 · Cited by 1,097
Mechanism of Toxicity in Rotenone Models of Parkinson's Disease
Sherer, T. B., Betarbet, R., Testa, C. M., Seo, B. B., Richardson, J. R., Kim, J. H., Miller, G. W., Yagi, T., Matsuno-Yagi, A., & Greenamyre, J. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10756.2003 · Cited by 1,072
Self-citationDopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice
Heikkila, R. E., Hess, A., & Duvoisin, R. C. (1984) · Science · doi:10.1126/science.6610213 · Cited by 1,009
‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease
Chan, C. S., Guzman, J. N., Ilijic, E., Mercer, J. N., Rick, C., Tkatch, T., Meredith, G. E., & Surmeier, D. J. (2007) · Nature · doi:10.1038/nature05865 · Cited by 904
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
Schapira, A. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70327-7 · Cited by 883
McCormack, A. L., Thiruchelvam, M., Manning-Bog, A. B., Thiffault, C., Langston, J. W., Cory-Slechta, D. A., & Di Monte, D. A. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0507 · Cited by 838
A highly reproducible rotenone model of Parkinson's disease
Cannon, J. R., Tapias, V., Na, H. M., Honick, A. S., Drolet, R. E., & Greenamyre, J. T. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.01.016 · Cited by 795
Self-citationToxin-induced models of Parkinson’s disease
Bové, J., Prou, D., Perier, C., & Przedborski, S. (2005) · NeuroRX · doi:10.1602/neurorx.2.3.484 · Cited by 739
The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice
Manning-Bog, A. B., McCormack, A. L., Li, J., Uversky, V. N., Fink, A. L., & Di Monte, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100560200 · Cited by 684
Origin and functional consequences of the complex I defect in Parkinson's disease
Swerdlow, R. H., Parks, J. K., Miller, S. W., Davis, R. E., Tuttle, J. B., Trimmer, P. A., Sheehan, J. P., Bennett, J. P., & Parker, W. D. (1996) · Annals of Neurology · doi:10.1002/ana.410400417 · Cited by 638
Jackson-Lewis, V., Jakowec, M., Burke, R. E., & Przedborski, S. (1995) · Neurodegeneration · doi:10.1016/1055-8330(95)90015-2 · Cited by 609
Costello, S., Cockburn, M., Bronstein, J., Zhang, X., & Ritz, B. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp006 · Cited by 581
Complex I Is the Major Site of Mitochondrial Superoxide Production by Paraquat
Cochemé, H. M., & Murphy, M. P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708597200 · Cited by 571
Prospects for new restorative and neuroprotective treatments in Parkinson's disease
Dunnett, S. B., & Björklund, A. (1999) · Nature · doi:10.1038/399a032 · Cited by 537
Fornai, F., Schlüter, O. M., Lenzi, P., Gesi, M., Ruffoli, R., Ferrucci, M., Lazzeri, G., Busceti, C. L., Pontarelli, F., Battaglia, G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409713102 · Cited by 526
Molecular mechanisms of L-DOPA-induced dyskinesia
Jenner, P. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2471 · Cited by 523
Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons
Werth, J., & Thayer, S. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-01-00348.1994 · Cited by 488
Mitochondria Are a Major Source of Paraquat-induced Reactive Oxygen Species Production in the Brain
Castello, P. R., Drechsel, D. A., & Patel, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700827200 · Cited by 477
Thiruchelvam, M., Richfield, E. K., Baggs, R. B., Tank, A. W., & Cory-Slechta, D. A. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09207.2000 · Cited by 471
Przedborski, S., Kostic, V, Jackson-Lewis, V, Naini, A., Simonetti, S., Fahn, S., Carlson, E., Epstein, C., & Cadet, J. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-05-01658.1992 · Cited by 456
Pesticide exposure and risk for Parkinson's disease
Ascherio, A., Chen, H., Weisskopf, M. G., O'Reilly, E., McCullough, M. L., Calle, E. E., Schwarzschild, M. A., & Thun, M. J. (2006) · Annals of Neurology · doi:10.1002/ana.20904 · Cited by 445
Pesticides and Parkinson’s Disease—Is There a Link?
Brown, T. P., Rumsby, P. C., Capleton, A. C., Rushton, L., & Levy, L. S. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8095 · Cited by 430
Lebouvier, T., Neunlist, M., Bruley des Varannes, S., Coron, E., Drouard, A., N'Guyen, J.-M., Chaumette, T., Tasselli, M., Paillusson, S., Flamand, M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012728 · Cited by 427
Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss
Brooks, A. I., Chadwick, C. A., Gelbard, H. A., Cory-Slechta, D. A., & Federoff, H. J. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01192-5 · Cited by 424
Schulz, J. B., Matthews, R. T., Muqit, M. M. K., Browne, S. E., & Beal, M. F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020936.x · Cited by 417
Ramsay, R. R., & Singer, T. P. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57434-8 · Cited by 412
Mitochondrial point mutations do not limit the natural lifespan of mice
Vermulst, M., Bielas, J. H., Kujoth, G. C., Ladiges, W. C., Rabinovitch, P. S., Prolla, T. A., & Loeb, L. A. (2007) · Nature Genetics · doi:10.1038/ng1988 · Cited by 404
Gainetdinov, R. R., Fumagalli, F., Jones, S. R., & Caron, M. G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031322.x · Cited by 353
Sherer, T. B., Richardson, J. R., Testa, C. M., Seo, B. B., Panov, A. V., Yagi, T., Matsuno‐Yagi, A., Miller, G. W., & Greenamyre, J. T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04333.x · Cited by 341
Self-citationComplex I and Parkinson's Disease
Greenamyre, J. T., Sherer, T. B., Betarbet, R., & Panov, A. V. (2001) · IUBMB Life · doi:10.1080/15216540152845939 · Cited by 337
Self-citationDeficiency of Inducible Nitric Oxide Synthase Protects Against MPTP Toxicity In Vivo
Dehmer, T., Lindenau, J., Haid, S., Dichgans, J., & Schulz, J. B. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742213.x · Cited by 337
Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease
Büeler, H. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.006 · Cited by 327
Thiruchelvam, M., Brockel, B. J., Richfield, E. K., Baggs, R. B., & Cory-Slechta, D. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02496-3 · Cited by 324
Uversky, V. N. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0937-z · Cited by 312
Cicchetti, F., Drouin-Ouellet, J., & Gross, R. E. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.06.005 · Cited by 311
Heikkila, R. E., Nicklas, W. J., Vyas, I., & Duvoisin, R. C. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90580-4 · Cited by 300
Mitochondrial Approaches for Neuroprotection
Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294
Abnormal mitochondrial dynamics and neurodegenerative diseases
Su, B., Wang, X., Zheng, L., Perry, G., Smith, M. A., & Zhu, X. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.09.013 · Cited by 294
Neurochemical findings in the MPTP model of Parkinson's disease
Schmidt, N., & Ferger, B. (2001) · Journal of Neural Transmission · doi:10.1007/s007020100004 · Cited by 290
Przedborski, S., & Vila, M. (2003) · PubMed · Cited by 286
PRZEDBORSKI, S., & VILA, M. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07476.x · Cited by 283
Thiruchelvam, M., McCormack, A., Richfield, E. K., Baggs, R. B., Tank, A. W., Di Monte, D. A., & Cory‐Slechta, D. A. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02781.x · Cited by 280
Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in parkinson's disease
Hattori, N., Tanaka, M., Ozawa, T., & Mizuno, Y. (1991) · Annals of Neurology · doi:10.1002/ana.410300409 · Cited by 276
Paraquat Neurotoxicity is Distinct from that of MPTP and Rotenone
Richardson, J. R., Quan, Y., Sherer, T. B., Greenamyre, J. T., & Miller, G. W. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi304 · Cited by 275
Self-citationYadava, N., & Nicholls, D. G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0212-07.2007 · Cited by 272
The rotenone model of Parkinson's disease: genes, environment and mitochondria
Greenamyre, J. T., Betarbet, R., & Sherer, T. B. (2003) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(03)00023-3 · Cited by 259
Self-citationChronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology
Drolet, R. E., Cannon, J. R., Montero, L., & Greenamyre, J. T. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.017 · Cited by 257
Self-citationMechanisms of Toxicity, Clinical Features, and Management of Diquat Poisoning: A Review
Jones, G. M., & Vale, J. A. (2000) · Journal of Toxicology: Clinical Toxicology · doi:10.1081/clt-100100926 · Cited by 251
Rapid ATP Loss Caused by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Mouse Brain
Chan, P., DeLanney, L. E., Irwin, I., Langston, J. W., & Di Monte, D. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02134.x · Cited by 241
ANDERSON, G., NOORIAN, A., TAYLOR, G., ANITHA, M., BERNHARD, D., SRINIVASAN, S., & GREENE, J. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.010 · Cited by 238
Zhang, J., Fitsanakis, V. A., Gu, G., Jing, D., Ao, M., Amarnath, V., & Montine, T. J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01525.x · Cited by 237
Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity
Gash, D. M., Rutland, K., Hudson, N. L., Sullivan, P. G., Bing, G., Cass, W. A., Pandya, J. D., Liu, M., Choi, D., Hunter, R. L., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21288 · Cited by 222
Developmental Exposure to the Pesticides Paraquat and Maneb and the Parkinson’s Disease Phenotype
Thiruchelvam, M., Richfield, E. K., Goodman, B. M., Baggs, R. B., & Cory-Slechta, D. A. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00092-x · Cited by 214
Pesticides and Parkinson's disease
Le Couteur, D. G., McLean, A. J., Taylor, M. C., Woodham, B. L., & Board, P. G. (1999) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(99)80077-8 · Cited by 213
Threshold Effects and Control of Oxidative Phosphorylation in Nonsynaptic Rat Brain Mitochondria
Davey, G. P., & Clark, J. B. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66041617.x · Cited by 209
Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate).
Meco, G., Bonifati, V, Vanacore, N., & Fabrizio, E. (1994) · Scandinavian Journal of Work, Environment & Health · doi:10.5271/sjweh.1394 · Cited by 200
Oxidative Stress and Energy Crises in Neuronal Dysfunction
Nicholls, D. G. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.002 · Cited by 198
Role of voltage-gated L-type Ca2+ channel isoforms for brain function
Striessnig, J., Koschak, A., Sinnegger-Brauns, M. J., Hetzenauer, A., Nguyen, N. K., Busquet, P., Pelster, G., & Singewald, N. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340903 · Cited by 185
Neurologic Effects of Manganese in Humans: A Review
Levy, B. S., & Nassetta, W. J. (2003) · International Journal of Occupational and Environmental Health · doi:10.1179/oeh.2003.9.2.153 · Cited by 182
Parkinson’s disease: genetic versus toxin‐induced rodent models
Terzioglu, M., & Galter, D. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06302.x · Cited by 173
Bignami, G. F. (1999) · Nature · doi:10.1038/19899 · Cited by 163
6-Hydroxydopamine (6-OHDA) induces Drp1-dependent mitochondrial fragmentation in SH-SY5Y cells
Gomez-Lazaro, M., Bonekamp, N. A., Galindo, M. F., Jordán, J., & Schrader, M. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.009 · Cited by 162
Ossowska, K., Wardas, J., Śmiałowska, M., Kuter, K. Z., Lenda, T., Wierońska, J. M., Zieba, B. A., Nowak, P. G., Dąbrowska, J., Bortel, A. B., et al. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04301.x · Cited by 149
Inden, M., Kitamura, Y., Abe, M., Tamaki, A., Takata, K., & Taniguchi, T. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.92 · Cited by 149
The Origins of Oxidant Stress in Parkinson's Disease and Therapeutic Strategies
Surmeier, D. J., Guzmán, J. N., Sánchez-Padilla, J., & Goldberg, J. A. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3521 · Cited by 142
Shimizu, K., Matsubara, K., Ohtaki, K., Fujimaru, S., Saito, O., & Shiono, H. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02750-1 · Cited by 142
Zhou, Y. F., Shie, F., Piccardo, P., Montine, T. J., & Zhang, J. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.048 · Cited by 135
Oxidative Damage to RNA in Neurodegenerative Diseases
Nunomura, A., Honda, K., Takeda, A., Hirai, K., Zhu, X., Smith, M. A., & Perry, G. L. (2006) · BioMed Research International · doi:10.1155/jbb/2006/82323 · Cited by 133
Effects of l ‐dopa and other amino acids against paraquat‐induced nigrostriatal degeneration
McCormack, A. L., & Monte, D. A. D. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01621.x · Cited by 131
Remmen, H. V., Qi, W., Sabia, M., Freeman, G. L., Estlack, L. E., Yang, H. C., Guo, Z. M., Huang, T., Strong, R., Lee, S., et al. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.03.016 · Cited by 130
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro
Rossetti, Z. L., Soroiut, A., Sharp, D. E., Hadjiconstantinou, M., & Neff, N. H. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90674-0 · Cited by 129
Ahmadi, F. A., Linseman, D. A., Grammatopoulos, T. N., Jones, S. M., Bouchard, R. J., Freed, C. R., Heidenreich, K. A., & Zawada, W. M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02068.x · Cited by 128
Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium.
Liu, Y., Roghani, A., & Edwards, R. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9074 · Cited by 124
Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain
Cerruti, C., Walther, D. M., Kuhar, M. J., & Uhl, G. R. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90187-t · Cited by 119
Tada‐Oikawa, S., Hiraku, Y., Kawanishi, M., & Kawanishi, S. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.06.013 · Cited by 118
Prolonged Toxicokinetics and Toxicodynamics of Paraquat in Mouse Brain
Prasad, K., Winnik, B., Thiruchelvam, M. J., Buckley, B., Mirochnitchenko, O., & Richfield, E. K. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.9932 · Cited by 117
Non-dopaminergic treatments in development for Parkinson's disease
Fox, S. H., Brotchie, J. M., & Lang, A. E. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70214-x · Cited by 116
Zhang, J., Graham, D. G., Montine, T. J., & Ho, Y.-S. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.1.53 · Cited by 114
Yang, W., & Tiffany‐Castiglioni, E. (2005) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390500226987 · Cited by 113
Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats
Liu, M., Choi, D., Hunter, R. L., Pandya, J. D., Cass, W. A., Sullivan, P. G., Kim, H., Gash, D. M., & Bing, G. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06497.x · Cited by 112
Petit-Paitel, A., Brau, F., Cazareth, J., & Chabry, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005491 · Cited by 112
Tapias, V., Escames, G., López, L. C., López, A., Camacho, E., Carriòn, M. D., Entrena, A., Gallo, M. Á., Espinosa, A., & Acuña-Castroviejo, D. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22123 · Cited by 112
Höllerhage, M., Matusch, A., Champy, P., Lombès, A., Ruberg, M., Oertel, W. H., & Höglinger, G. U. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.004 · Cited by 107
Desai, V. G., Feuers, R. J., Hart, R. W., & Ali, S. F. (1996) · Brain Research · doi:10.1016/0006-8993(95)01255-9 · Cited by 105
Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome
Gómez, C., Bandez, M. J., & Navarro, A. (2006) · Frontiers in bioscience · doi:10.2741/2128 · Cited by 104
MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut
Natale, G., Kastsiushenka, O., Fulceri, F., Ruggieri, S. A., Paparelli, A., & Fornai, F. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.076 · Cited by 101
Drechsel, D. A., & Patel, M. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp223 · Cited by 99
Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model
Tapias, V., Cannon, J. R., & Greenamyre, J. T. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22201 · Cited by 97
Self-citationParaquat leads to dopaminergic neural vulnerability in organotypic midbrain culture
Shimizu, K., Matsubara, K., Ohtaki, K., & Shiono, H. (2003) · Neuroscience Research · doi:10.1016/s0168-0102(03)00163-9 · Cited by 94
Arnold, B. A., Cassady, S. J., Laar, V. S. V., & Berman, S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.09.006 · Cited by 84
Cell Death Pathways in Parkinson's Disease: Role of Mitochondria
Yao, Z., & Wood, N. W. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2624 · Cited by 80
Zhang, X., Zhou, J.-Y., Chin, M. H., Schepmoes, A., Petyuk, V., Weitz, K., Petritis, B. O., Monroe, M. E., Camp, D., Wood, S. A., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr901024z · Cited by 80
Paraquat: A Useful Tool for thein vivoStudy of Mechanisms of Neuronal Cell Death
Corasaniti, M. T., Strongoli, M. C., Rotiroti, D., Bagetta, G., & Nisticò, G. (1998) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1998.tb01434.x · Cited by 73
Rat model of Parkinson's disease: Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+)
Yazdani, U., German, D. C., Liang, C., Manzino, L., Sonsalla, P. K., & Zeevalk, G. D. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.02.002 · Cited by 73
Maneb enhances MPTP neurotoxicity in mice.
Rn, T., Rogério, R., & Zanin, M. (1989) · PubMed · Cited by 73
Xie, W., Wan, O. W., & Chung, K. K. K. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.014 · Cited by 67
Klaidman, L. K., Adams, J. D., Jr., Leung, A. C., Kim, S. S., & Cadenas, E. (1993) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(93)90056-z · Cited by 66
Maneb potentiates paraquat neurotoxicity by inducing key Bcl‐2 family members
Fei, Q., & Ethell, D. W. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05293.x · Cited by 61
From the MPTP-treated primate to the treatment of motor complications in Parkinson's disease
Jenner, P. G. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70829-6 · Cited by 61
Singh, S., Kumar, S., & Dikshit, M. (2010) · Redox Report · doi:10.1179/174329210x12650506623447 · Cited by 61
Misiak, M., Beyer, C., & Arnold, S. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.04.009 · Cited by 55
Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice
Rojo, A. I., Montero, C., Salazar‐Roa, M., Close, R. M., Fernández‐Ruíz, J., Sánchez-González, M. Á., de Sagarra, M. R., Jackson-Lewis, V. R., Cavada, C., & Cuadrado, A. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05060.x · Cited by 54
Davey, G. P., Tipton, K. F., & Murphy, M. P. (1992) · Biochemical Journal · doi:10.1042/bj2880439 · Cited by 52
Corasaniti, M. T., DeFilippo, R. E., Rodinò, P., Nappi, G., & Nisticò, G. (1991) · PubMed · Cited by 47
Kilbride, S. M., Telford, J. E., Tipton, K. F., & Davey, G. P. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05441.x · Cited by 41
Ethylenebisdithiocarbamate enhances MPTP-induced striatal dopamine depletion in mice.
McGrew, D. M., Irwin, I., & Langston, J. W. (2000) · PubMed · Cited by 32
Differential calbindin-immunoreactivity in dopamine neurons projecting to the rat striatal complex
Barrot, M., Calzà, L., Pozza, M., Moal, M. L., & Piazza, P. V. (2000) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2000.01349.x · Cited by 16
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Cited by
Oxidative Stress and Antioxidants in Neurodegenerative Disorders
Olufunmilayo, E. O., Gerke-Duncan, M. B., & Holsinger, R. M. D. (2023) · Antioxidants · doi:10.3390/antiox12020517 · Cited by 670
Mitochondria as a Target of Environmental Toxicants
Meyer, J. N., Leung, M. C. K., Rooney, J. P., Sendoel, A., Hengartner, M. O., Kisby, G. E., & Bess, A. S. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft102 · Cited by 562
Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
Henrich, M. T., Oertel, W. H., Surmeier, D. J., & Geibl, F. F. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00676-7 · Cited by 406
Oxidative damage to macromolecules in human Parkinson disease and the rotenone model
Sanders, L. H., & Timothy Greenamyre, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.003 · Cited by 345
Protecting the mitochondrial powerhouse
Scheibye-Knudsen, M., Fang, E. F., Croteau, D. L., Wilson, D. M., & Bohr, V. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.11.002 · Cited by 334
Metadata
- Authors
- Martinez, T. N., & Greenamyre, J. T.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2012-05
- Volume
- 16
- Issue
- 9
- Pages
- 920-934
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2091416451
- Cited by
- 266
- References
- 121
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.